VivoSeq
Dermatology

Eczema

3

Pipeline Programs↗

6

Active Trials↗

5

Companies Involved↗

Eczema is an early-stage landscape with 3 programs across 5 companies. The most active players are Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, Eli Lilly, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Intelligence

Pipeline Metrics

Competitive Density

29/100

Pipeline Velocity

15/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

1 program

Phase 2Eli Lilly logo

Eli Lilly

1 program

Phase 2P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Phase 2Pfizer logo

Pfizer

0 programs

PreclinicalN

Nektar Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

13

clinical trials

Completed6 · 46%
Recruiting3 · 23%
Active, not recruiting2 · 15%
Unknown status1 · 8%
Not yet recruiting1 · 8%

Clinical Trials

Trial Activity

13 trials

Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients
Recruiting·NNational Human Genome Research Institute (NHGRI)·N/A·NCT00605878·530 enrolled
Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis
Recruiting·National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)·Phase 2·NCT01631617·130 enrolled
Development and Testing of a Digital Psychological Tool to Improve Symptom Burden in Dermatology Patients
Recruiting·NNational University Hospital, Singapore·Preclinical·NCT06702293·690 enrolled
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Active, not recruiting·Pfizer logoPfizer·Phase 2·NCT07216027·200 enrolled
A Herbal Compound for Eczema
Active, not recruiting·FFasa University of Medical Sciences·Phase 2·NCT06758752·110 enrolled
The Impact of Dietary Salt on the Severity of Eczema
Not yet recruiting·UUniversity of California, San Francisco·Phase 4·NCT07447063·40 enrolled
Role of Anti-IgE in Severe Childhood Eczema
Completed·GGuy's and St Thomas' NHS Foundation Trust·Phase 4·NCT02300701·62 enrolled
Efalizumab for Eczema
Completed·UUniversity of Medicine and Dentistry of New Jersey·Phase 2·NCT00146003·10 enrolled
A Study of LY3471851 in Participants With Eczema
Completed·NNektar Therapeutics·Phase 1·NCT04081350·48 enrolled
PGE2/IL-22 Pathway in Various Forms of Eczema
Completed·NNHS Lothian·N/A·NCT04133506·38 enrolled
Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema
Completed·UUniversity of California, San Diego·N/A·NCT00946478·40 enrolled
Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema
Completed·PProf. HON Kam Lun Ellis·N/A·NCT04986384·40 enrolled
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
Unknown status·UUniversity Medical Center Groningen·Phase 3·NCT03026907·116 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)